Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $3.8 million.

  • Prestige Consumer Healthcare's Other Non-Current Assets fell 4016.41% to $3.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.8 million, marking a year-over-year decrease of 4016.41%. This contributed to the annual value of $3.3 million for FY2025, which is 4282.97% down from last year.
  • According to the latest figures from Q4 2025, Prestige Consumer Healthcare's Other Non-Current Assets is $3.8 million, which was down 4016.41% from $3.4 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Other Non-Current Assets ranged from a high of $6.7 million in Q3 2024 and a low of $2.5 million during Q2 2021
  • For the 5-year period, Prestige Consumer Healthcare's Other Non-Current Assets averaged around $3.9 million, with its median value being $3.3 million (2022).
  • Per our database at Business Quant, Prestige Consumer Healthcare's Other Non-Current Assets surged by 9984.15% in 2023 and then crashed by 5147.63% in 2025.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Other Non-Current Assets stood at $2.9 million in 2021, then grew by 9.13% to $3.2 million in 2022, then soared by 99.84% to $6.3 million in 2023, then increased by 0.57% to $6.3 million in 2024, then plummeted by 40.16% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q4 2025, $3.4 million for Q3 2025, and $3.0 million during Q2 2025.